comparemela.com

Latest Breaking News On - Pharmaceuticals trading down - Page 37 : comparemela.com

Crinetics Pharmaceuticals (NASDAQ:CRNX) Releases Earnings Results, Misses Estimates By $0.01 EPS

Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.90) earnings per share for the quarter, missing the consensus estimate of ($0.89) by ($0.01), Briefing.com reports. Crinetics Pharmaceuticals had a negative net margin of 4,223.27% and a negative return on equity of 57.04%. The business’s revenue for […]

Dana-pizzuti
Robertw-baird
Stephenf-betz
Cantor-fitzgerald
Crinetics-pharmaceuticals
Blackrock-inc
Metlife-investment-management
Group-one-trading
Securities-exchange-commission
News-ratings-for-crinetics-pharmaceuticals-daily
Crinetics-pharmaceuticals-trading-down
Crinetics-pharmaceuticals-company-profile

Covestor Ltd Raises Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Covestor Ltd raised its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 564.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 797 shares of the company’s stock after purchasing an additional 677 shares during the period. Covestor Ltd’s holdings in Apellis […]

United-states
America
Davido-watson
Lukas-scheibler
Robertw-baird
Goldman-sachs-group
Covestor-ltd
Quarter-for-apellis-pharmaceuticals
Needham-company
Nasdaq
Vanguard-group-inc
News-ratings-for-apellis-pharmaceuticals-daily

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Corton Capital Inc.

Corton Capital Inc. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 35.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,276 shares of the pharmaceutical company’s stock after selling 701 shares during the quarter. Corton […]

Canada
Kristen-ambrose
Amit-sachdev
Corton-capital-inc
Capital-research-global-investors
Vertex-pharmaceuticals
Canaccord-genuity-group
Cantor-fitzgerald
Royal-bank
Quarter-for-vertex-pharmaceuticals
Securities-exchange-commission
Vertex-pharmaceuticals-trading-down

Aristotle Capital Management LLC Acquires New Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Aristotle Capital Management LLC purchased a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 175,757 shares of the specialty pharmaceutical company’s stock, valued at approximately $22,748,000. Aristotle Capital […]

Canada
United-states
Mark-douglas-smith
Aristotle-capital-management
Platinum-investment-management-ltd
Massmutual-trust-co
Nasdaq
First-republic-investment-management-inc
Jazz-pharmaceuticals-trading-down
Barclays
News-ratings-for-jazz-pharmaceuticals-daily
Jpmorgan-chase-co

Qube Research & Technologies Ltd Cuts Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Qube Research & Technologies Ltd Cuts Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
Blackrock
New-zealand-general
New-zealand
Wellington
United-states
Robertw-baird
Mark-douglas-smith
Quarter-for-jazz-pharmaceuticals
Royal-bank
Vanguard-group-inc
Securities-exchange-commission
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.